Primary diffuse large B-cell lymphoma of the breast

References

1. 1.↵
   1. Siegel RL,
   2. Miller KD,
   3. Fuchs HE,
   4. Jemal A.

   Cancer statistics, 2021. CA Cancer J Clin 2021; 71: 7-33.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Cheah CY,
   2. Campbell BA,
   3. Seymour JF.

   Primary breast lymphoma. Cancer Treat Rev 2014; 40: 900-908.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Pan K,
   2. Chlebowski RT,
   3. Mortimer JE,
   4. Gunter MJ,
   5. Rohan T,
   6. Vitolins MZ, et al.

   Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women’s Health Initiative. Cancer 2020; 126: 3638-3647.

   OpenUrlPubMed
4. 4.↵
   1. Srinivasan M,
   2. Arzoun H,
   3. Gk LB,
   4. Thangaraj SR.

   A systematic review: does insulin resistance affect the risk and survival outcome of breast cancer in women? Cureus 2022; 14: e21712.

   OpenUrl
5. 5.↵
   1. Matthews DR,
   2. Hosker JP,
   3. Rudenski AS,
   4. Naylor BA,
   5. Treacher DF,
   6. Turner RC.

   Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Younes A,
   2. Hilden P,
   3. Coiffier B,
   4. Hagenbeek A,
   5. Salles G,
   6. Wilson W, et al.

   International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann Oncol 2017; 28: 1436-1447.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Genco IS,
   2. Gur H,
   3. Hajiyeva S.

   Lymphoma of the breast: a clinicopathologic analysis of 51 cases with a specific emphasis on patients with a history of breast carcinoma. BREAST J 2021; 27: 456-460.

   OpenUrl
8. 8.↵
   1. Takahashi H,
   2. Sakai R,
   3. Sakuma T,
   4. Matsumura A,
   5. Miyashita K,
   6. Ishii Y, et al.

   Comparison of clinical features between primary and secondary breast diffuse large B cell lymphoma: a Yokohama Cooperative Study Group for hematology multicenter retrospective study. Indian J Hematol Blood Transfus 2021; 37: 60-66.

   OpenUrl
9. 9.↵
   1. Nguyen L,
   2. Papenhausen P,
   3. Shao H.

   The role of c-MYC in B-cell lymphomas: diagnostic and molecular aspects. Genes (Basel) 2017; 8: 116.

   OpenUrl
10. 10.↵
    1. Huang W,
    2. Medeiros LJ,
    3. Lin P,
    4. Wang W,
    5. Tang G,
    6. Khoury J, et al.

    MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas. Mod Pathol 2018; 31: 1470-1478.

    OpenUrl
11. 11.↵
    1. Huang S,
    2. Nong L,
    3. Wang W,
    4. Liang L,
    5. Zheng Y,
    6. Liu J, et al.

    Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma. Diagn Pathol 2019; 14: 81.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Luo H,
    2. Yi P,
    3. Wang W,
    4. Li K,
    5. Meng L,
    6. Li J, et al.

    Clinicopathological Features, Treatment, and prognosis in primary diffuse large B cell lymphoma of the breast: a retrospective study of 46 patients. Med Sci Monit 2019; 25: 8671-8682.

    OpenUrlPubMed
13. 13.↵
    1. Lamy T,
    2. Damaj G,
    3. Soubeyran P,
    4. Gyan E,
    5. Cartron G,
    6. Bouabdallah K, et al.

    R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma. Blood 2018; 131: 174-181.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Kachhawa P,
    2. Kachhawa K,
    3. Agrawal D,
    4. Sinha V,
    5. Sarkar PD,
    6. Kumar S.

    Association of dyslipidemia, increased insulin resistance, and serum CA 15-3 with increased risk of breast cancer in Urban areas of North and Central India. J Midlife Health 2018; 9: 85-91.

    OpenUrl
15. 15.↵
    1. Panigoro SS,
    2. Sutandyo N,
    3. Witjaksono F,
    4. Siregar NC,
    5. Ramli R,
    6. Hariani R, et al.

    The association between triglyceride-glucose index as a marker of insulin resistance and the risk of breast cancer. Front Endocrinol (Lausanne) 2021; 12: 745236.

    OpenUrl
16. 16.↵
    1. Gallagher EJ,
    2. Fei K,
    3. Feldman SM,
    4. Port E,
    5. Friedman NB,
    6. Boolbol SK, et al.

    Insulin resistance contributes to racial disparities in breast cancer prognosis in US women. Breast Cancer Res 2020; 22: 40.

    OpenUrl
17. 17.↵
    1. Chartoumpekis DV,
    2. Palliyaguru DL,
    3. Wakabayashi N,
    4. Khoo NK,
    5. Schoiswohl G,
    6. O’Doherty RM, et al.

    Notch intracellular domain overexpression in adipocytes confers lipodystrophy in mice. Mol Metab 2015; 4: 543-550.

    OpenUrl
18. 18.↵
    1. Hasan SS,
    2. Jabs M,
    3. Taylor J,
    4. Wiedmann L,
    5. Leibing T,
    6. Nordström V, et al.

    Endothelial Notch signaling controls insulin transport in muscle. EMBO Mol Med 2020; 12: e09271.

    OpenUrlCrossRef